Inex Pharmaceuticals Corporation has formed a joint venture with Elan Corporation, plc for the development and commercialisation of INEX’s lead product, Onco TCS, now being evaluated in human clinical trials as a treatment for a number of cancers. INEX and Elan have both contributed assets to the joint venture including worldwide rights to Onco TCS Read more about Inex Forms Joint Venture With Elan[…]